This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 29 PubMed articles · model: gemma4:31b
Summary
Frankincense, derived from Boswellia species such as B. sacra, is a resinous extract used traditionally for its anti-inflammatory, antimicrobial, and analgesic properties [PMID:27117114, PMID:35807419].
Background
Frankincense is an oleo-gum-resin obtained by wounding trees of the genus Boswellia, including B. sacra (endemic to Oman) and B. serrata (native to India, Middle East, and Northern Africa) [PMID:33151656, PMID:35789857, PMID:30566477].
Traditional uses
It has been used for centuries in Ayurvedic, Chinese, and Arab traditional medicines to treat inflammatory conditions, asthma, arthritis, gastric and hepatic disorders, and male fertility [PMID:33151656, PMID:35222678, PMID:35897864, PMID:24716181]. It is also used as incense in religious and cultural ceremonies [PMID:33151656, PMID:35243948].
Active compounds
The primary bioactive components are triterpenes, specifically boswellic acids (such as 11-keto-β-acetyl-boswellic acid and AKBA), and diterpenes, including cembranoids [PMID:27117114, PMID:34412004, PMID:24716181]. Essential oils contain mono- and diterpenes, with identified odorants including α-pinene, β-myrcene, and linalool [PMID:27117114, PMID:25468535].
Mechanism of action
Boswellia extracts exhibit anti-inflammatory, antioxidant, and anti-neoplastic activities [PMID:33235693, PMID:23237355]. In animal models, B. sacra methanolic extract suppressed oxidative stress and apoptosis in the testis while increasing antioxidant enzyme activity (superoxide dismutase and catalase) [PMID:35897864].
Clinical evidence
Evidence AKnee Osteoarthritis
Phytoextracts from the Boswellia genus were evaluated for efficacy using WOMAC and VAS scores [PMID:39314013]
A systematic review of RCTs was conducted to assess the effectiveness of B. serrata extracts [PMID:19091760]
Evidence DPancreatic Cancer
Essential oil from B. sacra induced human pancreatic cancer cell death in vitro and in a xenograft murine model [PMID:23237355]
Evidence DPain (Analgesia)
Crude extracts and essential oils of B. sacra showed analgesic effects in mice, comparable to aspirin in acetic acid-induced writhing tests [PMID:25312172]
Evidence DType II Diabetes (Rat model)
B. sacra oleo-gum resin extracts demonstrated antidiabetic and antioxidant properties in STZ-induced diabetic rats [PMID:39167989]
Safety & adverse effects
B. serrata extracts have not been linked to acute liver injury or serum aminotransferase elevations [PMID:33151656]. Allergic reactions to frankincense have been described but are reported as very rare [PMID:27975355]. One case of Boswellia resin-associated mania was reported [PMID:35426834].
Evidence summary
Evidence ranges from high-level systematic reviews and meta-analyses for osteoarthritis and general inflammation to preliminary in vitro and animal studies for cancer, diabetes, and male fertility.
2.PMID: 33151656 (2012) — Boswellia serrata, a potential antiinflammatory agent: an overview. · Indian journal of pharmaceutical sciences
3.PMID: 35426834 (2022) — Boswellia Resin (Frankincense)-Associated Mania. · American journal of therapeutics
4.PMID: 37761150 (2023) — Antimicrobial Activity of Frankincense (Boswellia sacra) Oil and Smoke against Pathogenic and Airborne Microbes. · Foods (Basel, Switzerland)
5.PMID: 35789857 (2022) — Genome structure and evolutionary history of frankincense producing Boswellia sacra.
Government sources
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
6.PMID: 39942962 (2025) — Aromatherapy and Essential Oils: Holistic Strategies in Complementary and Alternative Medicine for Integral Wellbeing. · Plants (Basel, Switzerland)
7.PMID: 23237355 (2012) — Frankincense essential oil prepared from hydrodistillation of Boswellia sacra gum resins induces human pancreatic cancer cell death in cultures and in a xenograft murine model. · BMC complementary and alternative medicine
9.PMID: 35243948 (2022) — Frankincense diterpenes as a bio-source for drug discovery. · Expert opinion on drug discovery
10.PMID: 30566477 (2018) — Endogenous phytohormones of frankincense producing Boswellia sacra tree populations. · PloS one
11.PMID: 34412004 (2021) — Cembranoids from Boswellia species. · Phytochemistry
12.PMID: 41124237 (2025) — Compositional Analysis of Cultivated and Wild-Harvested Boswellia sacra Frankincense Resin Essential Oils in Oman. · Chemistry & biodiversity
13.PMID: 33235693 (2020) — Effect of Boswellia species on the metabolic syndrome: A review. · Iranian journal of basic medical sciences
14.PMID: 27975355 (2016) — [Christmas from an allergist's perspective]. · Deutsche medizinische Wochenschrift (1946)
15.PMID: 32325952 (2020) — In Vitro Antimicrobial Activity of Frankincense Oils from Boswellia sacra Grown in Different Locations of the Dhofar Region (Oman). · Antibiotics (Basel, Switzerland)
16.PMID: 25468535 (2015) — Identification of odorants in frankincense (Boswellia sacra Flueck.) by aroma extract dilution analysis and two-dimensional gas chromatography-mass spectrometry/olfactometry. · Phytochemistry
17.PMID: 33028915 (2020) — Roles of ethylene, jasmonic acid, and salicylic acid and their interactions in frankincense resin production in Boswellia sacra Flueck. trees. · Scientific reports
18.PMID: 38816637 (2024) — Chemical Constituents and Pharmacological Properties of Frankincense: Implications for Anticancer Therapy. · Chinese journal of integrative medicine
19.PMID: 35807419 (2022) — Effects of Frankincense Compounds on Infection, Inflammation, and Oral Health. · Molecules (Basel, Switzerland)
20.PMID: 39314013 (2024) — Efficacy of Extracts of Oleogum Resin of Boswellia in the Treatment of Knee Osteoarthritis: A Systematic Review and Meta-Analysis. · Phytotherapy research : PTR
21.PMID: 39167989 (2024) — Antidiabetic and antioxidant properties of Boswellia sacra oleo-gum in streptozotocin-induced diabetic rats. · Journal of Ayurveda and integrative medicine
22.PMID: 29492734 (2018) — Conformational analysis of macrocyclic frankincense (Boswellia) diterpenoids. · Journal of molecular modeling
23.PMID: 35222678 (2022) — Taxonomical Investigation, Chemical Composition, Traditional Use in Medicine, and Pharmacological Activities of Boswellia sacra Flueck. · Evidence-based complementary and alternative medicine : eCAM
24.PMID: 35897864 (2022) — Beneficial Effect of Methanolic Extract of Frankincense (Boswellia Sacra) on Testis Mediated through Suppression of Oxidative Stress and Apoptosis. · Molecules (Basel, Switzerland)
26.PMID: 24716181 (2013) — Frankincense ( rǔ xiāng; boswellia species): from the selection of traditional applications to the novel phytotherapy for the prevention and treatment of serious diseases. · Journal of traditional and complementary medicine
27.PMID: 39401649 (2025) — Triterpenoids from Frankincense and Boswellia: A focus on their pharmacology and 13C-NMR assignments. · Phytochemistry
28.PMID: 25312172 (2014) — Analgesic effects of crude extracts and fractions of Omani frankincense obtained from traditional medicinal plant Boswellia sacra on animal models. · Asian Pacific journal of tropical medicine